title: Angiotensin converting enzyme inhibitors potentiate the vasorelaxant effect of fibrinogen-derived peptide 6A.
authors.affiliation: Department of Medicine, University of Florida College of Medicine, Gainesville.
authors.forename: K
authors.initials: K
authors.lastname: Saldeen
authors.forename: D L
authors.initials: DL
authors.lastname: Lawson
authors.forename: J L
authors.initials: JL
authors.lastname: Mehta
mesh_terms: D000595:Amino Acid Sequence; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D002216:Captopril / Q000008:administration & dosage / Q000031:analogs & derivatives; D004357:Drug Synergism; D015773:Enalaprilat / Q000008:administration & dosage; D005338:Fibrin Fibrinogen Degradation Products / Q000008:administration & dosage* / Q000737:chemistry; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D051381:Rats; D014664:Vasodilation / Q000187:drug effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D005338:Fibrin Fibrinogen Degradation Products; C026893:fibrinogen peptide 6A; C044958:zofenopril; D002216:Captopril; D015773:Enalaprilat